Inhibrx Biosciences President Sees 50,000‑Share Options Amid Mixed Insider Sales and Upcoming Director Elections—Market Watches for Confidence Shift
Inhibrx Biosciences insider moves: President’s 50K share option and junior execs’ purchases show long‑term confidence amid mixed investor sentiment and upcoming shareholder vote.
2 minutes to read
